CELL REPORTS MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2023-12-08 xiaozou_up20 来自广西

cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样

104 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-04-15 ms778638264889492 来自广东省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：肠道菌群
经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见

8 0

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-04-02 木贞来自湖北省

快过去20天了，怎么还在with editor

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-04-01 1208800am20暂无昵称来自江苏省

无

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-03-09 ms2000001504230883 来自广西

with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2023-03-09 123a7f4dm47暂无昵称来自上海

审稿速度:2.0 | 投稿命中率:25.0
经验分享：请教下，修回后一般多久有消息啊？还送外审么？

129 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-03-19 ms6000001492149190 来自山东省

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：基因治疗;眼科学
经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2023-06-28 yo3333 来自上海

审稿速度:4.0
偏重的研究方向：临床医学
经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了

5 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2023-05-24 DDPP 来自广东省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤免疫
经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。

95 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2173652, encodeId=c0a321e36528e, content=cell转投，转投三天了，还没分配编辑和稿号，这正常吗？请问大佬们有没有遇到过这样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ab745477244, createdName=xiaozou_up20, createdTime=Fri Dec 08 09:10:48 CST 2023, time=2023-12-08, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2198616, encodeId=a02021986166b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：肠道菌群 经验分享：2023.8月投稿，一审三个半月被拒，四个审稿人中，有一审稿人全程只挑了语法问题，另一审稿人完全曲解研究意义，最后也不想跟编辑battle了，感觉审稿人根本没有提出什么具有建设性价值的意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoo8sp4FZJ8xUBPs4sr9k65V6vP80krk6cxQo6WeSQz9BYIvWicbTgC6EUjK0SrhTVsO1poW7R6PBA/132, createdBy=ba195156176, createdName=ms778638264889492, createdTime=Mon Apr 15 14:50:26 CST 2024, time=2024-04-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196679, encodeId=4fe521966e90b, content=快过去20天了，怎么还在with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/895EBD2BD3678C550B88241DA556DBEB/100, createdBy=735d2308264, createdName=木贞, createdTime=Tue Apr 02 18:55:26 CST 2024, time=2024-04-02, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2196455, encodeId=6638219645592, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a2187480, createdName=1208800am20暂无昵称, createdTime=Mon Apr 01 15:05:35 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192257, encodeId=0b90219225e11, content=with editor 多久做决定呀，官网不是说6天嘛？现在都快20天了，咋还是with editor 状态呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc665418618, createdName=ms2000001504230883, createdTime=Sat Mar 09 16:24:39 CST 2024, time=2024-03-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2118459, encodeId=00542118459f1, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请教下，修回后一般多久有消息啊？还送外审么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a302426205, createdName=123a7f4dm47暂无昵称, createdTime=Thu Mar 09 10:31:00 CST 2023, time=2023-03-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2194011, encodeId=5d43219401120, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：基因治疗;眼科学 经验分享：我真是服了这个垃圾杂志了，编辑很墨迹，第一次投之后审稿时间很长，差不多3个月，催了才给的回复，三个审稿人，2个拒1个大修，我们的研究跟药物可能有点冲突，然后跟编辑battle了一下，编辑同意再次审核。大修之后2个审稿人没有任何意见，但是有一个审稿人一看就是傻逼，完全没有看我们文章的内容和我们对文章的完善，还是给了个拒。然后编辑还是给的拒。真应该去手刃了那个傻逼审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d87a6445676, createdName=ms6000001492149190, createdTime=Tue Mar 19 09:49:18 CST 2024, time=2024-03-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2145282, encodeId=6244214528220, content=审稿速度:4.0 偏重的研究方向：临床医学 经验分享：cell新子刊，看近期的文章质量，往20分去的。有幸中了一篇，历时7个月，本人肿瘤方向，主要做的临床样本和机制。前期慢的都想溜了，还好耐心等下去了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48ef2508535, createdName=yo3333, createdTime=Wed Jun 28 22:27:14 CST 2023, time=2023-06-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2138810, encodeId=3dbf2138810b5, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤免疫 经验分享：首个影响因子很高，仔细分析发现，引用次数前十的都是新冠相关的研究，预计最近两年的影响因子将持续下滑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=05323119086, createdName=DDPP, createdTime=Wed May 24 13:49:22 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2181986, encodeId=5e5b21819861b, content=想问一下，pre-accept之后大概多久发proof啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64935318954, createdName=尤文化, createdTime=Tue Jan 16 15:46:02 CST 2024, time=2024-01-16, status=1, ipAttribution=江苏省)]

2024-01-16 尤文化来自江苏省

想问一下，pre-accept之后大概多久发proof啊？

31 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务